Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01694
Species: Homo sapiens
Position : chr17:39611085-39689899
Year: 2024
Title: Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: lung adenocarcinoma
PMID:  38862995
MONDO: MONDO:0005061
Tissue: liver
Tissue Ontology ID: UBERON:0002107
Cell Source: Hep-G2
CVCL ID: CVCL_0027
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, Chromatin interaction assay, Functional perturbation assay; Endogenous enhancer perturbation; Chromatin interaction assay; Chromatin-state profiling; Disease-variant functional analysis
High Throughput Method: ChIP-seq, WGS, Hi-C, RNA-seq; ChIP-seq; Hi-C; Oxford Nanopore long-read sequencing; whole-genome sequencing
Low Throughput Method: CRISPR Knockout, RT-RT-qPCR, FACS, Western blot; CRISPR-Cas9 endogenous deletion/editing; ChIP
About Target Gene
Target gene : ERBB2
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg38) 1 found
Enhancer ID Position Tissue Cell Disease
E_01729 chr17:39611085-39689899 bronchus bronchial epithelial cell NA
Expression of Target Genes for the Enhancer